# Swedish Cardiac And Renal Failure Study-1

> **NCT07029503** · PHASE2 · RECRUITING · sponsor: **Karolinska Institutet** · enrollment: 40 (estimated)

## Conditions studied

- HFrEF - Heart Failure With Reduced Ejection Fraction
- Chronic Kidney Disease

## Interventions

- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT07029503
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-02
- **Final completion:** 2027-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07029503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07029503, "Swedish Cardiac And Renal Failure Study-1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07029503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*